October 01, 2025

Biomarkers May Help Quest for a Link Between Apnea and Alzheimer's

Links between obstructive sleep apnea and Alzheimer’s disease (AD) have long been thought to exist, but the long time horizon for Alzheimer's has been a barrier to investigation. Mount Sinai has now launched a study to assess whether patients who are successfully treated for obstructive sleep apnea demonstrate a slower decline in cognitive function and lower levels of plasma AD biomarkers compared to those who are untreated.

Mount Sinai New York

September 29, 2025

ACC Calls for Universal Inflammation Screening

New scientific statement positions hsCRP testing alongside cholesterol as evidence mounts for targeting residual inflammatory risk. 

Conexiant

September 26, 2025

UCL and UniQure Present New Data for Huntington’s Disease Gene Therapy

Progression slowed in Huntington’s Disease through AMT-130, a gene therapy under investigation.

The Medicine Maker

September 24, 2025

This Week’s Biopharma News: Phase III Trial for Parkinson’s Disease Cell Therapy

Our latest news roundup reports on new guidelines in Europe, Pfizer’s acquisition of Metsera, and funding for better pharmaceutical catalysts.

The Medicine Maker

September 18, 2025

Cancer-Induced Nerve Injury Identified as Driver of PD-1 Resistance Across Tumor Types

Researchers have uncovered that cancer cells degrade protective nerve coverings, causing cancer-induced nerve injury that can lead to chronic inflammation and resistance to anti–PD-1 immunotherapy, ac...

The ASCO Post

September 15, 2025

Pilot study tests ALS drug to treat chemo brain in cancer patients

A first-of-its-kind study tests ALS drug riluzole to restore cognitive function in cancer survivors.

UCI Health

September 11, 2025

How Mutations Affecting Purine Metabolism Shaped the Human Brain

Mouse models with human-specific ADSL variants have sex-specific effects on brain function 

The Analytical Scientist

January 01, 0001

Thrombocytopenia, Deep-Vein Thrombosis, and Pulmonary Emboli in a Patient With Primary CNS Lymphoma

Understanding the complexities of Primary Central Nervous System Lymphoma: an overview of diagnosis, treatment options, and prognosis.

JADPRO

January 01, 0001

2010 National Comprehensive Cancer Network (NCCN) Nursing Program: Role of the Advanced Practice Nurse in Quality Cancer Care™

Explore the complexities of chemotherapy-induced peripheral neuropathy and discover management strategies from Dr. Judith Pace at the Lurie Cancer Center.

JADPRO